NRC Health logo

NRC Health

NRC

NASDAQHealthcareMedical - Healthcare Information Services

Previous close

$22.19

+$0.37 · +1.70%

Aug 21, 4:00 PM ET

NRC company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

67

Undervalued

Momentum

58

Neutral

Sentiment

69

Bullish

Risk resilience

59

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Trent Green
Listed since
May 23, 2013
Employees
357

Market position

Day range

Current $22.19

52-week range

Current $22.19

Open
$21.89
Previous close
$21.82
Volume
339.03K
2.78× average
Average volume
122.03K
Average daily volume
Market cap
500.09M USD
Beta
0.37
Market reference 1
50-day average
$20.803
+6.67% above average
200-day average
$18.2357
+21.68% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
495.02M USD
P/E (TTM)
84.53×
P/B (TTM)
74.57×
P/S (TTM)
3.57×
EV / EBITDA
16.38×
Earnings yield
2.76%
Free cash flow yield
3.75%
Dividend yield
2.70%

Profitability & efficiency

Gross margin
66.79%
Operating margin
10.53%
Net margin
4.18%
Return on equity
82.92%
Return on assets
8.60%
Return on invested capital
14.36%

Financial health

Debt / equity
13.75×
Current ratio
0.55×
Altman Z-score
3.34
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends70%48%25%3%Gross margin, FY2021: 64.62%Gross margin, FY2022: 62.36%Gross margin, FY2023: 62.30%Gross margin, FY2024: 60.20%Gross margin, FY2025: 56.33%Operating margin, FY2021: 33.98%Operating margin, FY2022: 30.71%Operating margin, FY2023: 26.95%Operating margin, FY2024: 24.60%Operating margin, FY2025: 16.44%Net margin, FY2021: 25.32%Net margin, FY2022: 20.98%Net margin, FY2023: 20.84%Net margin, FY2024: 17.32%Net margin, FY2025: 8.44%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 64.62%. Gross margin FY2022 62.36%. Gross margin FY2023 62.30%. Gross margin FY2024 60.20%. Gross margin FY2025 56.33%. Operating margin FY2021 33.98%. Operating margin FY2022 30.71%. Operating margin FY2023 26.95%. Operating margin FY2024 24.60%. Operating margin FY2025 16.44%. Net margin FY2021 25.32%. Net margin FY2022 20.98%. Net margin FY2023 20.84%. Net margin FY2024 17.32%. Net margin FY2025 8.44%.

Income trends

Revenue

137.39M USD-3.96%

Operating income

22.59M USD-35.81%

Net income

11.6M USD-53.19%
Income trends across reported periods165.56M USD109.58M USD53.59M USD−2.4M USDRevenue, FY2021: 147.95M USDRevenue, FY2022: 151.57M USDRevenue, FY2023: 148.58M USDRevenue, FY2024: 143.06M USDRevenue, FY2025: 137.39M USDOperating income, FY2021: 50.27M USDOperating income, FY2022: 46.54M USDOperating income, FY2023: 40.05M USDOperating income, FY2024: 35.19M USDOperating income, FY2025: 22.59M USDNet income, FY2021: 37.47M USDNet income, FY2022: 31.8M USDNet income, FY2023: 30.97M USDNet income, FY2024: 24.78M USDNet income, FY2025: 11.6M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 147.95M USD. Revenue FY2022 151.57M USD. Revenue FY2023 148.58M USD. Revenue FY2024 143.06M USD. Revenue FY2025 137.39M USD. Operating income FY2021 50.27M USD. Operating income FY2022 46.54M USD. Operating income FY2023 40.05M USD. Operating income FY2024 35.19M USD. Operating income FY2025 22.59M USD. Net income FY2021 37.47M USD. Net income FY2022 31.8M USD. Net income FY2023 30.97M USD. Net income FY2024 24.78M USD. Net income FY2025 11.6M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue137.39M USD143.06M USD148.58M USD151.57M USD147.95M USD
Cost of goods sold60M USD56.93M USD56.02M USD57.05M USD52.35M USD
Gross profit77.4M USD86.13M USD92.57M USD94.52M USD95.6M USD
Selling, general, and administrative54.81M USD44.91M USD46.58M USD42.7M USD38.96M USD
Operating expenses54.81M USD50.93M USD52.52M USD47.98M USD45.33M USD
Interest income111K USD125K USD820K USD168K USD14K USD
Interest expense4.76M USD2.6M USD862K USD1.21M USD1.67M USD
Depreciation and amortization7.62M USD6.02M USD5.9M USD5.28M USD6.37M USD
Operating income22.59M USD35.19M USD40.05M USD46.54M USD50.27M USD
Net income11.6M USD24.78M USD30.97M USD31.8M USD37.47M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
50%
1 beat, 1 miss, 0 met estimates
Average EPS surprise
+121.83%
2 comparable reports
Latest EPS result
0.31
Estimate -0.15 · Beat by 306.67%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.40.20.01-0.19Q1 '25No estimateQ2 '25No estimateQ3 '25No estimateQ4 '25No estimateQ1 '26No estimateQ2 '26No estimateQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 11, 2025: actual 0.36, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 28, 2025: actual 0.25, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 28, 2025: actual 0.28, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 27, 2025: actual 0.23, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 3, 2026: actual 0.16, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 28, 2026: actual 0.21, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 28, 2026: actual 0.31, estimate -0.15, surprise +306.67%, Beat. Q4 2026, reported Oct 26, 2026: actual —, estimate 0.21, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates38.38M36.28M34.18M32.07MQ1 '25No estimateQ2 '25No estimateQ3 '25No estimateQ4 '25No estimateQ1 '26No estimateQ2 '26No estimateQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 11, 2025: actual 36.91M USD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 28, 2025: actual 33.55M USD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 28, 2025: actual 34.04M USD, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 27, 2025: actual 34.61M USD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 3, 2026: actual 35.19M USD, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 28, 2026: actual 34.8M USD, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 28, 2026: actual 35.39M USD, estimate 34.9M USD, surprise +1.41%, Beat. Q4 2026, reported Oct 26, 2026: actual —, estimate 35.8M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

1 institution
CitizensmaintainMarket Outperform

NRC news

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$0.52

2025 complete year+8.3% since 2021

2026 partial: $0.32

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 25, 2026

$0.16

Quarterly

Record Sep 25, 2026 · Payment Oct 9, 2026

Dividend

Ex-dividend Jun 26, 2026

$0.16

Quarterly

Record Jun 26, 2026 · Payment Jul 10, 2026

Dividend

Ex-dividend Mar 27, 2026

$0.16

Quarterly

Record Mar 27, 2026 · Payment Apr 10, 2026

Dividend

Ex-dividend Dec 26, 2025

$0.16

Quarterly

Record Dec 26, 2025 · Payment Jan 9, 2026

Dividend

Ex-dividend Sep 26, 2025

$0.12

Quarterly

Record Sep 26, 2025 · Payment Oct 10, 2025

Dividend

Ex-dividend Jun 27, 2025

$0.12

Quarterly

Record Jun 27, 2025 · Payment Jul 11, 2025

NRC peers

ETFs holding NRC

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research NRC

research.disclaimer